Smofkabiven Peripheral 210 mg

SMOFKABIVEN Peripheral 210 mg is an intravenous emulsion containing lysine (lysine acetate). It is designed to provide essential amino acids for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd.

SMOFKABIVEN Peripheral 210 mg is used for nutritional support in patients who cannot consume food orally. It provides essential amino acids, including lysine, which are crucial for various bodily functions. This emulsion is often used in clinical settings to support patients' nutritional needs during intravenous therapy.

The effects of SMOFKABIVEN Peripheral 210 mg include providing essential amino acids to the body. These amino acids are vital for protein synthesis, tissue repair, and overall nutritional health. The emulsion is designed to be well-tolerated when administered intravenously.

SMOFKABIVEN Peripheral 210 mg should be handled with care and administered under medical supervision. It is important to follow proper storage and handling guidelines to maintain the integrity of the emulsion. Patients should be monitored for any adverse reactions during administration.

SMOFKABIVEN Peripheral 210 mg may interact with other medications or supplements. It is important to inform healthcare providers about all current medications to avoid potential interactions. Always consult a healthcare professional before starting any new treatment.